LOS ANGELES, CA - January 15, 2013 - - Aurizon Mines Ltd (USA) (AMEX: AZK) increased 1.75% to $4.66 on a traded volume of 4.54 million shares. The Company admits the announcement made on January 14, 2013 by Alamos Gold Incorporated of its commencement of an unsolicited bid for all of the issued and outstanding shares of Aurizon that it currently does not own. The Company is in the process of reviewing and evaluating the Alamos Offer with its financial and legal advisors.
Will AZK Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=AZK
Inovio Pharmaceuticals Inc (AMEX: INO) jumped up 3.13% to $0.66 on a traded volume of 1.28 million shares. The Company and its development partner VGX International will move Inovio's hepatitis C (HCV) DNA vaccine into a phase I/IIa clinical trial by the end of 2013. This advancement is based on outstanding results of a preclinical study which demonstrated for the first time that a multi-antigen SynCon HCV vaccine can generate robust T-cell responses not only in the blood but, more prominently, in the liver, an organ known to supress T-cell activity.
How Should Investors Trade INO After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=INO
New Gold Inc (USA) (AMEX: NGD) moved up 3.07% to $11.07 on a traded volume of 1.49 million shares. The 52-week range for the stock is $7.13 and $12.84. The Company has Price/Sales ratio of 6.92 and Price/Book ratio of 2.08. The 50-Day Moving Average and 200-Day Moving Average prices is $10.76 and $10.90 respectively.
Get Free Special Trend Analysis On NGD Here http://beststocksdaily.com/p2/index.php?company=NGD
Hemispherx BioPharma Inc (AMEX: HEB) moved down 4.44% to $0.263 on a traded volume of 1.05 million shares. Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Hemispherx Biopharma Inc and certain of its officers. The class action filed in United States District Court, Eastern District of Pennsylvania, on behalf of a class consisting of all persons or entities who purchased or otherwise acquired securities of Hemispherx between March 22, 2012 and December 17, 2012
Get Free Special Trend Analysis On HEB Here http://beststocksdaily.com/p2/index.php?company=HEB
Neostem Inc (AMEX: NBS) declined 0.88% to $0.610 on a traded volume of 662k shares. The Company announced that Dr. Aaron Havens of the University of Michigan has won the Milo Hellman Research Award from the American Association of Orthodontists for his research in collaboration with NeoStem.
Get Free Special Trend Analysis On NBS Here http://beststocksdaily.com/p2/index.php?company=NBS
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA